Corebridge Financial Inc. cut its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 5.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 82,219 shares of the business services provider's stock after selling 4,424 shares during the quarter. Corebridge Financial Inc. owned approximately 0.16% of Exponent worth $7,326,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Intech Investment Management LLC bought a new stake in Exponent during the 3rd quarter worth about $933,000. Charles Schwab Investment Management Inc. grew its stake in shares of Exponent by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 517,612 shares of the business services provider's stock valued at $59,670,000 after purchasing an additional 7,163 shares during the last quarter. Citigroup Inc. increased its holdings in shares of Exponent by 174.7% in the third quarter. Citigroup Inc. now owns 48,309 shares of the business services provider's stock valued at $5,569,000 after purchasing an additional 30,723 shares in the last quarter. Cerity Partners LLC raised its position in Exponent by 20.1% in the 3rd quarter. Cerity Partners LLC now owns 21,823 shares of the business services provider's stock worth $2,516,000 after purchasing an additional 3,659 shares during the last quarter. Finally, FMR LLC lifted its holdings in Exponent by 48.4% during the 3rd quarter. FMR LLC now owns 10,278 shares of the business services provider's stock worth $1,185,000 after buying an additional 3,351 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Exponent
In other Exponent news, VP Richard Reiss sold 1,736 shares of the firm's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now directly owns 1,800 shares of the company's stock, valued at approximately $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is owned by corporate insiders.
Exponent Stock Performance
EXPO traded up $0.94 during mid-day trading on Wednesday, reaching $81.72. The stock had a trading volume of 64,774 shares, compared to its average volume of 272,928. The stock has a market capitalization of $4.15 billion, a P/E ratio of 38.54 and a beta of 0.77. Exponent, Inc. has a 52 week low of $77.30 and a 52 week high of $115.75. The firm's fifty day simple moving average is $86.30 and its two-hundred day simple moving average is $95.27.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period in the previous year, the business earned $0.41 EPS. As a group, analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.